Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor. (Q34506608)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor. |
scientific article |
Statements
Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor (English)
Rajeev S Bhide
Zhen-Wei Cai
Yong-Zheng Zhang
Ligang Qian
Donna Wei
Stephanie Barbosa
Louis J Lombardo
Robert M Borzilleri
Xiaoping Zheng
Laurence I Wu
Joel C Barrish
Soong-Hoon Kim
Kenneth Leavitt
Arvind Mathur
Leslie Leith
Sam Chao
Barri Wautlet
Steven Mortillo
Robert Jeyaseelan
Daniel Kukral
Amrita Kamath
Aberra Fura
Viral Vyas
Punit Marathe
Celia D'Arienzo
George Derbin
Joseph Fargnoli